array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Regeneron Pharmaceuticals Inc" ["slug"]=> string(38) "c469a-us-regeneron-pharmaceuticals-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77" ["description"]=> string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. " ["address_street"]=> string(25) "777 Old Saw Mill River Rd" ["address_place"]=> string(9) "Tarrytown" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1988-02-08" ["website_domain"]=> string(13) "regeneron.com" ["website_url"]=> string(25) "https://www.regeneron.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(10368) ["article_count"]=> int(2432) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(102) "White House keeps focus on lowering drug prices, turns Regeneron's contract language into new standard" ["snippet_en"]=> string(285) "As President Joe Biden struggles in the most recent 2024 general election polls, the White House is keeping its focus on drug prices, going after pharma for the second time in as many weeks, with plans to find new ways to interact with industry on the federal government's terms. While" ["url"]=> string(120) "https://endpts.com/white-house-keeps-focus-on-lowering-drug-prices-turns-regenerons-contract-language-into-new-standard/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a8dc7049-0cf9-4523-8a5e-cc5c3d0ba73d" ["source"]=> string(10) "endpts.com" ["publication_date"]=> string(10) "2023-12-14" ["categories"]=> array(6) { [0]=> string(24) "Access and affordability" [1]=> string(19) "Government Policies" [2]=> string(24) "Government Interventions" [3]=> string(8) "Politics" [4]=> string(20) "Contract negotiation" [5]=> string(11) "US Politics" } } [1]=> array(7) { ["title_en"]=> string(76) "Biden's pick to lead NIH clears hurdle — despite Bernie's vote against her" ["snippet_en"]=> string(184) "The Vermont senator held up the nomination process for Dr. Monica Bertagnolli to lead the health agency in order to make a point about drug prices. Now, he says he'll vote against her." ["url"]=> string(117) "https://www.kasu.org/health-science/2023-10-24/bidens-pick-to-lead-nih-clears-hurdle-despite-bernies-vote-against-her" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e10b92fa-6cb8-449d-93b8-8954eb98fcaf" ["source"]=> string(8) "kasu.org" ["publication_date"]=> string(10) "2023-10-24" ["categories"]=> array(3) { [0]=> string(8) "Epidemic" [1]=> string(8) "Politics" [2]=> string(11) "US Politics" } } [2]=> array(7) { ["title_en"]=> string(103) "Pharmalittle: Biden's NIH nominee will get a hearing; top Democrat backs bill to ban PBM spread pricing" ["snippet_en"]=> string(109) "President Biden’s nominee to lead NIH will get a hearing next month, perhaps thanks to a drug-pricing deal." ["url"]=> string(118) "https://www.statnews.com/pharmalot/2023/09/11/biden-nih-bertagnolli-pbm-spread-pricing-abortion-pill-novartis-moderna/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8f150ef0-5031-4a15-ba15-1af13b7900ad" ["source"]=> string(12) "statnews.com" ["publication_date"]=> string(10) "2023-09-11" ["categories"]=> array(4) { [0]=> string(8) "Epidemic" [1]=> string(19) "Government Policies" [2]=> string(8) "Politics" [3]=> string(7) "Funding" } } [3]=> array(7) { ["title_en"]=> string(75) "Marc Thiessen: Why President Trump is confident in reelection and reopening" ["snippet_en"]=> string(225) "Three weeks before Election Day, President Donald Trump is trailing in the polls, but he remains confident of victory. “We have tremendous enthusiasm,” he says in an interview. “They only have negative enthusiasm. . . ." ["url"]=> string(113) "https://www.sunjournal.com/2022/10/18/marc-thiessen-why-president-trump-is-confident-in-reelection-and-reopening/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8bc3c95e-9485-4e57-a5bb-4c7ad49e8210" ["source"]=> string(14) "sunjournal.com" ["publication_date"]=> string(10) "2022-10-18" ["categories"]=> array(1) { [0]=> string(8) "Politics" } } [4]=> array(7) { ["title_en"]=> string(79) "Biden Administration asks Supreme Court to reject Amgen's Repatha patent appeal" ["snippet_en"]=> string(204) "The Biden Administration told the U.S. Supreme Court on Wednesday that it should turn down a request by Amgen Inc to review a decision that invalidated patents on its blockbuster cholesterol drug Repatha." ["url"]=> string(128) "https://www.reuters.com/legal/litigation/biden-administration-asks-supreme-court-reject-amgens-repatha-patent-appeal-2022-09-21/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9e70236c-11af-4500-a315-b4c1b7f7d827" ["source"]=> string(11) "reuters.com" ["publication_date"]=> string(10) "2022-09-21" ["categories"]=> array(10) { [0]=> string(5) "Legal" [1]=> string(46) "Management of Legal and Regulatory Environment" [2]=> string(27) "Business Model & Innovation" [3]=> string(11) "Legislation" [4]=> string(19) "Government Policies" [5]=> string(8) "Verdicts" [6]=> string(8) "Politics" [7]=> string(21) "Intellectual Property" [8]=> string(14) "Product Review" [9]=> string(11) "US Politics" } } [5]=> array(7) { ["title_en"]=> string(84) "Trump ordered McDonald's from hospital after COVID drug 'started kicking in': report" ["snippet_en"]=> string(162) "Former president Donald Trump reportedly had McDonald's brought to Walter Reed hospital after he was taken there following his COVID-19 diagnosis in October 2020." ["url"]=> string(49) "https://www.rawstory.com/donald-trump-2655919869/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/14fa566c-3f1d-4f27-a3a3-d5a2c7c18d9c" ["source"]=> string(12) "rawstory.com" ["publication_date"]=> string(10) "2021-12-04" ["categories"]=> array(3) { [0]=> string(8) "Epidemic" [1]=> string(8) "Politics" [2]=> string(11) "US Politics" } } [6]=> array(7) { ["title_en"]=> string(75) "Sunburn — The morning read of what’s hot in Florida politics — 9.8.21" ["snippet_en"]=> string(62) "Get ready for an espresso shot of Florida politics and policy." ["url"]=> string(109) "https://floridapolitics.com/archives/455490-sunburn-the-morning-read-of-whats-hot-in-florida-politics-9-8-21/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b61004bb-9523-447a-9903-4231f84b35b4" ["source"]=> string(19) "floridapolitics.com" ["publication_date"]=> string(10) "2021-09-08" ["categories"]=> array(2) { [0]=> string(8) "Epidemic" [1]=> string(8) "Politics" } } [7]=> array(7) { ["title_en"]=> string(90) "People seeking touted COVID-19 antibody treatments are largely left to fend for themselves" ["snippet_en"]=> string(176) "Months after Donald Trump credited an experimental antibody therapy for his recovery, only a trickle of the product has gone to regular people, who have to find a way to get it" ["url"]=> string(121) "https://chicago.suntimes.com/coronavirus/2021/1/20/22240567/covid-antibody-monoclonal-treatments-experimental-coronavirus" ["image_url"]=> string(78) "https://images.businessradar.com/articles/982a377d-4b9b-4f0d-91c6-ae93baef0bfb" ["source"]=> string(12) "suntimes.com" ["publication_date"]=> string(10) "2021-01-20" ["categories"]=> array(2) { [0]=> string(8) "Epidemic" [1]=> string(8) "Politics" } } [8]=> array(7) { ["title_en"]=> string(63) "A Trump-touted covid therapy awaits proof to back up his boasts" ["snippet_en"]=> string(250) "One day before the Republican National Convention kicked off, President Donald Donald Trump and top drug regulator Stephen Hahn held a White House press conference to tout emergency authorization of a promising covid-19 treatment. Convalescent plasma" ["url"]=> string(104) "https://www.thetelegraph.com/news/article/a-trump-touted-covid-therapy-awaits-proof-to-back-15835808.php" ["image_url"]=> string(78) "https://images.businessradar.com/articles/61584f81-b4ca-43d0-9ef4-1caa34dc083a" ["source"]=> string(16) "thetelegraph.com" ["publication_date"]=> string(10) "2020-12-30" ["categories"]=> array(3) { [0]=> string(8) "Epidemic" [1]=> string(8) "Politics" [2]=> string(11) "US Politics" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(197) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(193) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(152) } [3]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(99) } [4]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(95) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(83) } [6]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(70) } [7]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(61) } [8]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(51) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(50) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(46) } [11]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(44) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [13]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(35) } [14]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(34) } [15]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(33) } [16]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(33) } [17]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(32) } [18]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(31) } [19]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(31) } [20]=> array(2) { ["name"]=> string(14) "Product Review" ["count"]=> int(31) } [21]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(29) } [22]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(29) } [23]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(23) } [28]=> array(2) { ["name"]=> string(11) "Sponsorship" ["count"]=> int(20) } [29]=> array(2) { ["name"]=> string(8) "Politics" ["count"]=> int(20) } } } c469a-us-regeneron-pharmaceuticals-inc